Developer docs
API playgroundTry for free, no card

Search company profiles

ETView Medical

Full company profile

uuid003737h

Namestring
ETView Medical
Legal namestring
ETView Medical Ltd.
Websiteurl
etview.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

ETView Medical is an Israel-based medical device company that developed the world's first single-use double lumen endobronchial tube with an integrated CMOS video camera and LED lighting for continuous airway visualization during One Lung Ventilation (OLV) procedures. Founded in 2006 and headquartered in Misgav, the company's flagship VivaSight platform enables real-time monitoring of tube placement throughout thoracic surgery, addressing the clinical risks of tube malpositioning and dislocation without requiring separate bronchoscope confirmation. The product is supplied sterile and single-use, eliminating cross-contamination risk between patients, and is available in multiple French sizes (35, 37, 39, 41 Fr) for left and right lung isolation. Functional benefits cited include faster intubation, reduced bronchoscope confirmation dependency, immediate malposition detection, and up to USD 47.65 cost savings per procedure compared with conventional DLT-plus-reusable-bronchoscope workflows, with 13 clinical studies supporting the product.

In 2017, Ambu A/S (Nasdaq Copenhagen: AMBUb.CO) acquired ETView Medical, integrating the VivaSight portfolio into its airway management and anesthesia product line. The acquisition gave ETView's technology access to Ambu's global distributor network across Europe, the Americas, and Asia Pacific, as well as integration with Ambu's aView 2 Advance full-HD endoscopy monitor, which supports Dual View mode streaming simultaneous video from VivaSight 2 DLT and Ambu aScope 4 Broncho Slim bronchoscopes. The VivaSight platform has since expanded beyond the original DLT to include the VivaSight 2 SLT and VivaSight Endobronchial Blocker, positioning it as a broader single-use airway visualization portfolio. ETView Medical operates as a fully absorbed subsidiary under Ambu ownership, with no independent ownership structure remaining; product pricing is quote-based and disclosed only on request. Leadership includes CFO Ronen Koyfman and COO Yonat Granot, and the company received early funding from Trendlines Group in 2009.

Short descriptiontext

ETView Medical, an Israel-based medical device firm (acquired by Ambu A/S in 2017), develops the VivaSight single-use double-lumen endobronchial tube with an integrated CMOS camera for continuous airway visualization during One Lung Ventilation in thoracic surgery, serving hospitals and surgical centers globally.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMisgav, Israel
HQ citystring
Misgav
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
single-use airway devices, double-lumen endobronchial tubes, one lung ventilation, integrated camera medical devices, thoracic anesthesia equipment
Industry1 code
1Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction)
CodeHLAHAGAFPrimaryYes
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Airway Management Medical Devices
Social media profiles2 records
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1VivaSight 2 DLT Kit - LEFT
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available in 35 Fr, 37 Fr, 39 Fr & 41 Fr sizes. Product numbers: 412351000 (35 Fr), 412371000 (37 Fr), 412391000 (39 Fr), 412411000 (41 Fr). Pricing requires quote request.

ambu.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1VivaSight
Description

Single-use double-lumen tubes and airway management devices with integrated camera technology for one-lung ventilation procedures. Originally developed by ETView Medical, now marketed under Ambu brand following acquisition.

ambu.com
Core offering1 text field

ETView Medical develops and manufactures single-use airway management devices with integrated video camera technology. Its flagship VivaSight 2 DLT is a sterile, single-use double-lumen endobronchial tube with an embedded CMOS camera and LED lighting for continuous real-time visualization during One Lung Ventilation (OLV) procedures. The product is available in 35 Fr, 37 Fr, 39 Fr, and 41 Fr sizes and integrates with Ambu's aView 2 Advance monitor for simultaneous video streaming.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Cost savings of up to USD 47.65 per procedure compared to conventional DLT with reusable bronchoscope
+3 more records
Product overview1 text field

ETView Medical (technology licensed to Ambu) offers the VivaSight platform of airway management products featuring integrated camera technology for continuous visualization during lung isolation procedures. The core product is the VivaSight 2 DLT - a single-use double lumen tube with embedded CMOS camera and LED lights that connects to the Ambu aView 2 Advance monitor. The VivaSight system enables real-time monitoring of tube placement throughout One Lung Ventilation procedures, improving patient safety by allowing immediate detection and correction of malpositioning without compromising ventilation. The complete OLV solution includes the VivaSight 2 DLT, VivaSight 2 SLT, VivaSight Endobronchial Blocker, Ambu bronchoscopes (aScope 5 Broncho and aScope 4 Broncho Slim), and aView 2 Advance full-HD monitor with Dual View capability.

Product and service1 record
1Ambu VivaSight 2 DLT (Double Lumen Tube)
CategoryAirway Management Medical Devices - Double-Lumen Endobronchial Tubes
Description

Sterile, single-use double-lumen endobronchial tube with an integrated video camera for One Lung Ventilation (OLV) procedures. Provides continuous real-time airway visualization to detect and correct tube malpositioning. Available in 35 Fr, 37 Fr, 39 Fr, and 41 Fr sizes for left or right lung isolation. Connects to the Ambu aView 2 Advance full-HD monitor with Dual View capability.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cook Medical manufactures airway management devices including endobronchial blockers and related single-use products used during OLV. It competes for hospital airway management budget alongside VivaSight 2.

TypeEmerging player
Description

Verathon (GlideScope) is a leader in video laryngoscopy and airway visualization. While focused on intubation rather than OLV specifically, its visualization-first approach to airway management makes it a comparable innovation-driven peer.

TypeDirect peer
Description

Medtronic (via its former Covidien/Mallinckrodt heritage) sells Shiley and Mallinckrodt double-lumen tubes and other airway management devices. It competes head-to-head with VivaSight 2 in the global DLT market and has a much larger commercial footprint.

TypeDirect peer
Description

Vyaire Medical is a pure-play respiratory and airway management device company offering DLTs, bronchoscopes, and ventilation consumables. It targets the same surgical airway customers as ETView's VivaSight line.

TypeEmerging player
Description

Pulmodyne specializes in single-use respiratory and airway devices including bronchoscopy and oxygenation products. It serves the same anesthesia and thoracic surgery customer base with innovative single-use consumables, partially overlapping with VivaSight's positioning.

TypeBroad incumbent
Description

Ambu is ETView's parent company and a broad incumbent in single-use endoscopy and airway management. Ambu's aScope bronchoscope family and VivaSight 2 DLT together form an integrated OLV solution, but Ambu also overlaps broadly with the peers above across endoscopy.

TypeDirect peer
Description

ICU Medical acquired Smiths Medical's airway and DLT portfolio (Portex brand), making it a direct competitor in single-use DLTs and airway consumables. Like VivaSight, these are sold into hospital surgical suites for thoracic procedures.

TypeBroad incumbent
Description

Karl Storz is a global leader in rigid and flexible endoscopy, including bronchoscopes and visualization systems used in thoracic surgery. Its reusable visualization systems compete in the same procedural workflows as VivaSight 2.

TypeDirect peer
Description

Intersurgical designs and manufactures a wide range of single-use airway management products including endobronchial tubes and related anesthesia consumables. It is a direct competitive supplier to hospitals performing OLV.

TypeDirect peer
Description

Teleflex manufactures and sells double-lumen endobronchial tubes (Rusch, Sheridan, Hudson RCI brands) and a broad airway management portfolio. It is one of the most direct competitors to the VivaSight 2 DLT in the OLV/thoracic surgery market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ETView Medical

Airway Management Medical Devicesetview.com

ETView Medical, an Israel-based medical device firm (acquired by Ambu A/S in 2017), develops the VivaSight single-use double-lumen endobronchial tube with an integrated CMOS camera for continuous airway visualization during One Lung Ventilation in thoracic surgery, serving hospitals and surgical centers globally.

What ETView Medical does

ETView Medical is an Israel-based medical device company that developed the world's first single-use double lumen endobronchial tube with an integrated CMOS video camera and LED lighting for continuous airway visualization during One Lung Ventilation (OLV) procedures. Founded in 2006 and headquartered in Misgav, the company's flagship VivaSight platform enables real-time monitoring of tube placement throughout thoracic surgery, addressing the clinical risks of tube malpositioning and dislocation without requiring separate bronchoscope confirmation. The product is supplied sterile and single-use, eliminating cross-contamination risk between patients, and is available in multiple French sizes (35, 37, 39, 41 Fr) for left and right lung isolation. Functional benefits cited include faster intubation, reduced bronchoscope confirmation dependency, immediate malposition detection, and up to USD 47.65 cost savings per procedure compared with conventional DLT-plus-reusable-bronchoscope workflows, with 13 clinical studies supporting the product.

In 2017, Ambu A/S (Nasdaq Copenhagen: AMBUb.CO) acquired ETView Medical, integrating the VivaSight portfolio into its airway management and anesthesia product line. The acquisition gave ETView's technology access to Ambu's global distributor network across Europe, the Americas, and Asia Pacific, as well as integration with Ambu's aView 2 Advance full-HD endoscopy monitor, which supports Dual View mode streaming simultaneous video from VivaSight 2 DLT and Ambu aScope 4 Broncho Slim bronchoscopes. The VivaSight platform has since expanded beyond the original DLT to include the VivaSight 2 SLT and VivaSight Endobronchial Blocker, positioning it as a broader single-use airway visualization portfolio. ETView Medical operates as a fully absorbed subsidiary under Ambu ownership, with no independent ownership structure remaining; product pricing is quote-based and disclosed only on request. Leadership includes CFO Ronen Koyfman and COO Yonat Granot, and the company received early funding from Trendlines Group in 2009.

ETView Medical firmographics

Firmographics
Name
ETView Medical
Legal name
ETView Medical Ltd.
Website
https://etview.com
Company type
Private
Founded year
2006
Operating status
Acquired
Headcount range
11–50 employees
Short description
ETView Medical, an Israel-based medical device firm (acquired by Ambu A/S in 2017), develops the VivaSight single-use double-lumen endobronchial tube with an integrated CMOS camera for continuous airway visualization during One Lung Ventilation in thoracic surgery, serving hospitals and surgical centers globally.
Ownership category
akta.pro rank

ETView Medical industry classification

Industry
Product category
Airway Management Medical Devices
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction) (HLAHAGAF)

Keywords

  • Single-use airway devices
  • Double-lumen endobronchial tubes
  • One lung ventilation
  • Integrated camera medical devices
  • Thoracic anesthesia equipment

Where ETView Medical is headquartered

Location

Headquarters

HQ city
Misgav
HQ country
Israel
HQ region
Middle East

Markets served

ETView Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goVivaSight 2 DLT Kit - LEFT

Distribution channels3 records

Marketing channels3 records

ETView Medical product offering

Product offering

Core offering

ETView Medical develops and manufactures single-use airway management devices with integrated video camera technology. Its flagship VivaSight 2 DLT is a sterile, single-use double-lumen endobronchial tube with an embedded CMOS camera and LED lighting for continuous real-time visualization during One Lung Ventilation (OLV) procedures. The product is available in 35 Fr, 37 Fr, 39 Fr, and 41 Fr sizes and integrates with Ambu's aView 2 Advance monitor for simultaneous video streaming.

Product overview

ETView Medical (technology licensed to Ambu) offers the VivaSight platform of airway management products featuring integrated camera technology for continuous visualization during lung isolation procedures. The core product is the VivaSight 2 DLT - a single-use double lumen tube with embedded CMOS camera and LED lights that connects to the Ambu aView 2 Advance monitor. The VivaSight system enables real-time monitoring of tube placement throughout One Lung Ventilation procedures, improving patient safety by allowing immediate detection and correction of malpositioning without compromising ventilation. The complete OLV solution includes the VivaSight 2 DLT, VivaSight 2 SLT, VivaSight Endobronchial Blocker, Ambu bronchoscopes (aScope 5 Broncho and aScope 4 Broncho Slim), and aView 2 Advance full-HD monitor with Dual View capability.

Differentiator

Problem solved

Functional benefit

Brands

  • VivaSight: Single-use double-lumen tubes and airway management devices with integrated camera technology for one-lung ventilation procedures. Originally developed by ETView Medical, now marketed under Ambu brand following acquisition.

Products and services

  • Ambu VivaSight 2 DLT (Double Lumen Tube) Sterile, single-use double-lumen endobronchial tube with an integrated video camera for One Lung Ventilation (OLV) procedures. Provides continuous real-time airway visualization to detect and correct tube malpositioning. Available in 35 Fr, 37 Fr, 39 Fr, and 41 Fr sizes for left or right lung isolation. Connects to the Ambu aView 2 Advance full-HD monitor with Dual View capability.

Quantifiable outcome

  • Cost savings of up to USD 47.65 per procedure compared to conventional DLT with reusable bronchoscope
  • +3 more outcomes

Companies that use ETView Medical

Customer profile

Segments1 record

Ideal customer profiles1 record

ETView Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

ETView Medical partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights5 records

ETView Medical competitors and assessment

Company assessment

Direct peers

  • Cook Medical: Cook Medical manufactures airway management devices including endobronchial blockers and related single-use products used during OLV. It competes for hospital airway management budget alongside VivaSight 2.
  • Medtronic: Medtronic (via its former Covidien/Mallinckrodt heritage) sells Shiley and Mallinckrodt double-lumen tubes and other airway management devices. It competes head-to-head with VivaSight 2 in the global DLT market and has a much larger commercial footprint.
  • Vyaire Medical: Vyaire Medical is a pure-play respiratory and airway management device company offering DLTs, bronchoscopes, and ventilation consumables. It targets the same surgical airway customers as ETView's VivaSight line.
  • ICU Medical (Smiths Medical): ICU Medical acquired Smiths Medical's airway and DLT portfolio (Portex brand), making it a direct competitor in single-use DLTs and airway consumables. Like VivaSight, these are sold into hospital surgical suites for thoracic procedures.
  • Intersurgical: Intersurgical designs and manufactures a wide range of single-use airway management products including endobronchial tubes and related anesthesia consumables. It is a direct competitive supplier to hospitals performing OLV.
  • Teleflex: Teleflex manufactures and sells double-lumen endobronchial tubes (Rusch, Sheridan, Hudson RCI brands) and a broad airway management portfolio. It is one of the most direct competitors to the VivaSight 2 DLT in the OLV/thoracic surgery market.

Emerging players

  • Verathon: Verathon (GlideScope) is a leader in video laryngoscopy and airway visualization. While focused on intubation rather than OLV specifically, its visualization-first approach to airway management makes it a comparable innovation-driven peer.
  • Pulmodyne: Pulmodyne specializes in single-use respiratory and airway devices including bronchoscopy and oxygenation products. It serves the same anesthesia and thoracic surgery customer base with innovative single-use consumables, partially overlapping with VivaSight's positioning.

Broad incumbents

  • Ambu A/S: Ambu is ETView's parent company and a broad incumbent in single-use endoscopy and airway management. Ambu's aScope bronchoscope family and VivaSight 2 DLT together form an integrated OLV solution, but Ambu also overlaps broadly with the peers above across endoscopy.
  • Karl Storz: Karl Storz is a global leader in rigid and flexible endoscopy, including bronchoscopes and visualization systems used in thoracic surgery. Its reusable visualization systems compete in the same procedural workflows as VivaSight 2.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ETView Medical social profiles

Digital presence

ETView Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ETView Medical leadership team

Management profile

Number of profiles

Profiles2 records

ETView Medical funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ETView Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ETView Medical

What does ETView Medical do?

ETView Medical develops and manufactures single-use airway management devices with integrated video camera technology. Its flagship VivaSight 2 DLT is a sterile, single-use double-lumen endobronchial tube with an embedded CMOS camera and LED lighting for continuous real-time visualization during One Lung Ventilation (OLV) procedures. The product is available in 35 Fr, 37 Fr, 39 Fr, and 41 Fr sizes and integrates with Ambu's aView 2 Advance monitor for simultaneous video streaming.

Is ETView Medical a public or private company?

ETView Medical is a private company. It is classified as corporate owned and is currently acquired.

When was ETView Medical founded?

ETView Medical was founded in 2006. It employs 11 to 50 people.

Where is ETView Medical based?

ETView Medical is headquartered in Misgav, Israel, in the Middle East region.

Who are ETView Medical's main competitors?

Direct peers on record are Cook Medical, Medtronic, Vyaire Medical, ICU Medical (Smiths Medical), Intersurgical and Teleflex. Emerging players are Verathon and Pulmodyne. Broad incumbents are Ambu A/S and Karl Storz.

Does ETView Medical have an API?

No public API is recorded for ETView Medical.

What industry is ETView Medical in?

ETView Medical's product category is Airway Management Medical Devices. Its primary akta.pro industry code is HLAHAGAF, Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction). Its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magDanish Device Firm to Acquire E.T.View MedicalAmbu A/S, a Danish medical device firm, is acquiring E.T.View Medical Ltd. in a deal valued at $16 million, which was unanimously approved by E.T.View's Board of Directors on June 21. The Trendlines Group, which holds a 26.5% stake in E.T.View, expects to receive approximately $3.3 million in net proceeds from the sale, marking an important financial milestone for the company.PR NewswireAirway Management Devices Market Analysis By Product (Supraglottic, Infraglottic, Resuscitators, Laryngoscopes), By Application (Anesthesia, Emergency Medicine), By End Use, And Segment Forecasts, 201The global airway management devices market is projected to reach USD 2.1 billion by 2025, driven by rising chronic respiratory disease prevalence and technological advancements in video laryngoscopes and other devices. Grand View Research's market analysis covers product segments, applications in anesthesia and emergency medicine, and regional outlook, with North America holding dominant market share in 2016 while Asia Pacific is expected to grow at the fastest rate. Ambu A/S completed the acquisition of ETView Medical Ltd. in September 2016 to expand its product portfolio and cater to unmet patient needs.GlobeNewswireAmbu finalises acquisition of ETView Medical Ltd.Ambu finalized its acquisition of Israeli-based ETView Medical Ltd. after shareholder approval and regulatory conditions were met. The deal, announced on 22 June 2016, strengthens Ambu's visualisation portfolio.